It is of note that free KU is not able to sensitize cells to DOX treatment (Figure 1A,B), which suggests that encapsulated ATM inhibitors play a specific and functional role in sensitizing resistant breast cancer cells to anticancer therapies. This evidence concerns the gene ATM and breast carcinoma.